Oaktree Acquisition III Life Sciences Postpones Shareholder Meeting to Oct. 23, 2026

Oaktree Acquisition III Life Sciences postponed its shareholder meeting from October 16 to October 23, 2026, to solicit additional proxy votes. Shareholders will consider extending the deadline to complete an initial business combination. The rescheduled meeting will begin at 10 a.m. Eastern Time in New York, with virtual participation available. Previously submitted proxies remain valid unless properly revoked; shareholders who have voted need no further action unless changing their vote. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Oaktree Acquisition III Life Sciences Corp. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001193125-26-423329), on October 16, 2026, and is solely responsible for the information contained therein. (C)